Literature DB >> 10358951

Aortic valve replacement in a patient with idiopathic thrombocytopenic purpura.

T Kumamoto1, S Higashi, T Sumida.   

Abstract

A patient with aortic regurgitation and idiopathic thrombocytopenic purpura underwent a successful valve replacement. Cardiac surgery requiring a cardiopulmonary bypass in idiopathic thrombocytopenic purpura can be safely carried out with the preoperative intravenous administration of high-dose gammaglobulin, which may thereby reduce the need for either perioperative transfusion or prophylactic splenectomy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358951     DOI: 10.1007/BF03217967

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  9 in total

1.  Coronary artery bypass in idiopathic thrombocytopenia without splenectomy.

Authors:  L D Thompson; A J Cohen; F H Edwards; M J Barry
Journal:  Ann Thorac Surg       Date:  1989-11       Impact factor: 4.330

2.  Coronary artery bypass grafting in chronic immune-mediated thrombocytopenic purpura: preoperative treatment with intravenous immunoglobulin and corticosteroids.

Authors:  E P Hofmeister
Journal:  Mil Med       Date:  1995-12       Impact factor: 1.437

3.  Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass.

Authors:  J M Porter; D Silver
Journal:  J Thorac Cardiovasc Surg       Date:  1968-12       Impact factor: 5.209

4.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura.

Authors:  R E Schmidt; U Budde; G Schäfer; I Stroehmann
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

5.  Heart operation in a patient with refractory idiopathic thrombocytopenic purpura.

Authors:  N P Briffa; J A Dyde; R I Harris
Journal:  J Thorac Cardiovasc Surg       Date:  1994-01       Impact factor: 5.209

Review 6.  Coronary artery bypass grafting in immune thrombocytopenic purpura.

Authors:  T C Mathew; R Vasudevan; L Leb; S M Pezzella; A T Pezzella
Journal:  Ann Thorac Surg       Date:  1997-10       Impact factor: 4.330

7.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Authors:  P Imbach; S Barandun; V d'Apuzzo; C Baumgartner; A Hirt; A Morell; E Rossi; M Schöni; M Vest; H P Wagner
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

8.  Combined coronary revascularization and splenectomy.

Authors:  R Koike; H Suma; T Oku; H Satoh; Y Sawada; A Takeuchi
Journal:  Ann Thorac Surg       Date:  1989-12       Impact factor: 4.330

9.  Mitral valve replacement and splenectomy in a patient with chronic idiopathic thrombocytopenic purpura.

Authors:  J M Marõnas; P Llamas; J M Caffarena
Journal:  Thorac Cardiovasc Surg       Date:  1982-12       Impact factor: 1.827

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.